MCO · Moodys Corp /De/
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $4.68 | Q2 2026 | — |
|
|
|||
| MA Adjusted Operating Margin non-GAAP | 33.6% | Q2 2026 | — |
|
|
|||
| MA ARR | $3,661M | Q2 2026 | — |
|
|
|||
| MCO Adjusted Operating Margin non-GAAP | 55.3% | Q2 2026 | — |
|
|
|||
| MIS Adjusted Operating Margin non-GAAP | 68.3% | Q2 2026 | — |
|
|
|||
| Free Cash Flow non-GAAP | $844M | Q1 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net cash provided by operating activities 939M
-95M Capital additions
= Free Cash Flow 844M
|
|||
| Adjusted Operating Margin non-GAAP | 51.1% | Full Year 2025 | — |
| ARR non-GAAP | 3.5B | Full Year 2025 | — |
| ARR growth non-GAAP | 8% | Full Year 2025 | — |
| Banking ARR non-GAAP | 8% | Full Year 2025 | — |
| Data & Information ARR non-GAAP | 7% | Full Year 2025 | — |
| Decision Solutions ARR non-GAAP | 10% | Full Year 2025 | — |
| Insurance ARR non-GAAP | 7% | Full Year 2025 | — |
| KYC ARR non-GAAP | 15% | Full Year 2025 | — |
| Recurring revenue | 97% | 4Q 2025 | — |
| Recurring revenue growth | 11% | Full Year 2025 | — |
| Research & Insights ARR non-GAAP | 8% | Full Year 2025 | — |
| Transaction revenue decline | -30% | 4Q 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Financial Data & Stock Exchanges — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MCO
this stock
Moodys Corp /De/
|
$83.83B | -4.8% | +16.6% | 30.7 | 1.8% |
|
SPGI
S&P Global Inc.
|
$121.37B | -16.7% | +7.1% | 27.4 | 1.7% |
|
CME
Cme Group Inc.
|
$95.21B | -0.2% | +11.1% | 22.5 | 1.6% |
|
ICE
Intercontinental Exchange, Inc.
|
$84.12B | -6.8% | -2.1% | 21.2 | 1.6% |
|
LSEGY
London Stock Exchange Group plc
|
$55.87B | -5.0% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MCO | +0.2% | -0.2% | +17.9% | +1.2% | -4.8% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -5.4% | -3.5% | +6.7% | -1.9% | -17.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.